Eligibility criteria
Condition
Major Depressive Disorder
Sex
Females and Males
Age
19 + years
Inclusion criteria
Show details
1. Adults 19 years of age or older, who have been received at least one dose of PRISTIQ®
for the treatment of Major depressive disorder (MDD).
2. Patients who have been received for the first time after signed the 'data privacy
statement'
Exclusion criteria
Show details
Patients to whom PRISTIQ® is contraindicated as per the local labeling;
1. Hypersensitivity to desvenlafaxine succinate, venlafaxine hydrochloride or any
excipients in the PRISTIQ® formulation.
2. Serotonin syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders
with PRISTIQ® or Do not use PRISTIQ® within 14 days of stopping an MAOI intended to
treat psychiatric disorders